PDB Short entry for 2P4I HEADER TRANSFERASE 12-MAR-07 2P4I TITLE EVOLUTION OF A HIGHLY SELECTIVE AND POTENT 2-(PYRIDIN-2-YL)-1,3,5- TITLE 2 TRIAZINE TIE-2 KINASE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOPOIETIN-1 RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: TYROSINE-PROTEIN KINASE RECEPTOR TIE-2, HTIE2, TYROSINE- COMPND 5 PROTEIN KINASE RECEPTOR TEK, P140 TEK, TUNICA INTERNA ENDOTHELIAL COMPND 6 CELL KINASE, CD202B ANTIGEN; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TEK, TIE2; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS TIE-2 KINASE INHIBITOR TRIAZINE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.F.BELLON REVDAT 4 21-FEB-24 2P4I 1 REMARK REVDAT 3 24-FEB-09 2P4I 1 VERSN REVDAT 2 20-NOV-07 2P4I 1 JRNL REVDAT 1 20-MAR-07 2P4I 0 JRNL AUTH B.L.HODOUS,S.D.GEUNS-MEYER,P.E.HUGHES,B.K.ALBRECHT,S.BELLON, JRNL AUTH 2 J.BREADY,S.CAENEPEEL,V.J.CEE,S.C.CHAFFEE,A.COXON,M.EMERY, JRNL AUTH 3 J.FRETLAND,P.GALLANT,Y.GU,D.HOFFMAN,R.E.JOHNSON,R.KENDALL, JRNL AUTH 4 J.L.KIM,A.M.LONG,M.MORRISON,P.R.OLIVIERI,V.F.PATEL, JRNL AUTH 5 A.POLVERINO,P.ROSE,P.TEMPEST,L.WANG,D.A.WHITTINGTON,H.ZHAO JRNL TITL EVOLUTION OF A HIGHLY SELECTIVE AND POTENT JRNL TITL 2 2-(PYRIDIN-2-YL)-1,3,5-TRIAZINE TIE-2 KINASE INHIBITOR. JRNL REF J.MED.CHEM. V. 50 611 2007 JRNL REFN ISSN 0022-2623 JRNL PMID 17253678 JRNL DOI 10.1021/JM061107L REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 3 NUMBER OF REFLECTIONS : 22844 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.248 REMARK 3 R VALUE (WORKING SET) : 0.246 REMARK 3 FREE R VALUE : 0.303 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1224 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.56 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1241 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 70.16 REMARK 3 BIN R VALUE (WORKING SET) : 0.2860 REMARK 3 BIN FREE R VALUE SET COUNT : 71 REMARK 3 BIN FREE R VALUE : 0.3800 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3965 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 178 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.40000 REMARK 3 B22 (A**2) : 1.14000 REMARK 3 B33 (A**2) : -2.54000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.538 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.338 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.246 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.683 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.894 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.842 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4135 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5613 ; 1.222 ; 1.985 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 500 ; 5.549 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 180 ;38.016 ;23.778 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 659 ;17.053 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 25 ;16.465 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 622 ; 0.083 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3130 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2009 ; 0.208 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2826 ; 0.305 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 213 ; 0.177 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 62 ; 0.229 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 9 ; 0.095 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2613 ; 0.543 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4024 ; 0.950 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1793 ; 1.059 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1589 ; 1.671 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 2 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 838 A 904 4 REMARK 3 1 B 836 B 904 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 303 ; 0.54 ; 0.50 REMARK 3 MEDIUM THERMAL 1 A (A**2): 303 ; 0.87 ; 2.00 REMARK 3 REMARK 3 NCS GROUP NUMBER : 2 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 905 A 1117 4 REMARK 3 1 B 905 B 1117 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 2 A (A): 1596 ; 0.51 ; 0.50 REMARK 3 MEDIUM THERMAL 2 A (A**2): 1596 ; 0.82 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2P4I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-MAR-07. REMARK 100 THE DEPOSITION ID IS D_1000041955. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUN-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22844 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 76.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.31500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14-18% PEG 3350, 0.2M TRI-POTASSIUM REMARK 280 CITRATE (PH 6.5-7.5) AND 2% ISOPROPANOL., PH 7.0, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.13100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 87.78550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.59450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 87.78550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.13100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.59450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 808 REMARK 465 ASN A 809 REMARK 465 ASN A 810 REMARK 465 PRO A 811 REMARK 465 ASP A 812 REMARK 465 PRO A 813 REMARK 465 THR A 814 REMARK 465 ILE A 815 REMARK 465 TYR A 816 REMARK 465 PRO A 817 REMARK 465 VAL A 818 REMARK 465 LEU A 819 REMARK 465 ASP A 820 REMARK 465 TRP A 821 REMARK 465 ASN A 822 REMARK 465 ASP A 823 REMARK 465 ILE A 824 REMARK 465 LYS A 825 REMARK 465 PHE A 826 REMARK 465 GLN A 827 REMARK 465 ASP A 828 REMARK 465 VAL A 829 REMARK 465 ILE A 830 REMARK 465 GLY A 831 REMARK 465 GLU A 832 REMARK 465 GLY A 833 REMARK 465 ASN A 834 REMARK 465 PHE A 835 REMARK 465 GLY A 836 REMARK 465 GLN A 837 REMARK 465 LYS A 844 REMARK 465 LYS A 845 REMARK 465 ASP A 846 REMARK 465 GLY A 847 REMARK 465 LEU A 848 REMARK 465 MET A 857 REMARK 465 LYS A 858 REMARK 465 GLU A 859 REMARK 465 TYR A 860 REMARK 465 ALA A 861 REMARK 465 SER A 862 REMARK 465 LYS A 863 REMARK 465 ASP A 864 REMARK 465 ASP A 865 REMARK 465 HIS A 866 REMARK 465 ARG A 867 REMARK 465 ASP A 868 REMARK 465 PHE A 869 REMARK 465 ALA A 870 REMARK 465 ARG A 895 REMARK 465 GLY A 896 REMARK 465 TYR A 897 REMARK 465 LEU A 898 REMARK 465 GLY A 988 REMARK 465 GLN A 989 REMARK 465 GLU A 990 REMARK 465 VAL A 991 REMARK 465 TYR A 992 REMARK 465 CYS A 1118 REMARK 465 SER A 1119 REMARK 465 ALA A 1120 REMARK 465 GLU A 1121 REMARK 465 GLU A 1122 REMARK 465 ALA A 1123 REMARK 465 ALA A 1124 REMARK 465 LYS B 808 REMARK 465 ASN B 809 REMARK 465 ASN B 810 REMARK 465 PRO B 811 REMARK 465 ASP B 812 REMARK 465 PRO B 813 REMARK 465 THR B 814 REMARK 465 ILE B 815 REMARK 465 TYR B 816 REMARK 465 PRO B 817 REMARK 465 VAL B 818 REMARK 465 LEU B 819 REMARK 465 ASP B 820 REMARK 465 TRP B 821 REMARK 465 ASN B 822 REMARK 465 ASP B 823 REMARK 465 ILE B 824 REMARK 465 LYS B 825 REMARK 465 PHE B 826 REMARK 465 GLN B 827 REMARK 465 ASP B 828 REMARK 465 VAL B 829 REMARK 465 ILE B 830 REMARK 465 GLY B 831 REMARK 465 GLU B 832 REMARK 465 GLY B 833 REMARK 465 ASN B 834 REMARK 465 PHE B 835 REMARK 465 LYS B 844 REMARK 465 LYS B 845 REMARK 465 ASP B 846 REMARK 465 GLY B 847 REMARK 465 LEU B 848 REMARK 465 TYR B 860 REMARK 465 ALA B 861 REMARK 465 SER B 862 REMARK 465 ARG B 895 REMARK 465 GLY B 896 REMARK 465 TYR B 897 REMARK 465 LEU B 898 REMARK 465 SER B 986 REMARK 465 ARG B 987 REMARK 465 GLY B 988 REMARK 465 GLN B 989 REMARK 465 GLU B 990 REMARK 465 VAL B 991 REMARK 465 TYR B 992 REMARK 465 VAL B 993 REMARK 465 LYS B 994 REMARK 465 LYS B 995 REMARK 465 THR B 996 REMARK 465 MET B 997 REMARK 465 CYS B 1118 REMARK 465 SER B 1119 REMARK 465 ALA B 1120 REMARK 465 GLU B 1121 REMARK 465 GLU B 1122 REMARK 465 ALA B 1123 REMARK 465 ALA B 1124 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 839 CG CD1 CD2 REMARK 470 ARG A 842 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 849 CG CD NE CZ NH1 NH2 REMARK 470 MET A 850 CG SD CE REMARK 470 ARG A 856 CG CD NE CZ NH1 NH2 REMARK 470 HIS A 894 CG ND1 CD2 CE1 NE2 REMARK 470 TYR A 899 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 916 CG CD CE NZ REMARK 470 LEU A 985 CG CD1 CD2 REMARK 470 SER A 986 OG REMARK 470 VAL A 993 CG1 CG2 REMARK 470 GLU A1058 CG CD OE1 OE2 REMARK 470 ARG A1099 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 837 CG CD OE1 NE2 REMARK 470 LEU B 839 CG CD1 CD2 REMARK 470 ARG B 842 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 849 CG CD NE CZ NH1 NH2 REMARK 470 MET B 850 CG SD CE REMARK 470 ARG B 856 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 858 CG CD CE NZ REMARK 470 GLU B 859 CG CD OE1 OE2 REMARK 470 LYS B 863 CG CD CE NZ REMARK 470 ARG B 867 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 893 CG CD OE1 OE2 REMARK 470 HIS B 894 CG ND1 CD2 CE1 NE2 REMARK 470 TYR B 899 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 916 CG CD CE NZ REMARK 470 LEU B 985 CG CD1 CD2 REMARK 470 GLU B1058 CG CD OE1 OE2 REMARK 470 ARG B1099 CG CD NE CZ NH1 NH2 REMARK 470 GLU B1109 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH1 ARG A 999 O HOH A 72 2.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 850 -75.90 -60.85 REMARK 500 CYS A 892 -176.71 163.93 REMARK 500 ASP A 964 42.54 -148.81 REMARK 500 TYR A1012 -17.01 67.57 REMARK 500 CYS B 892 -162.79 173.81 REMARK 500 ASP B 923 74.38 -156.65 REMARK 500 ARG B 963 -17.21 82.50 REMARK 500 ASP B 964 46.55 -146.81 REMARK 500 ASN B 975 31.36 70.22 REMARK 500 PHE B 983 -137.59 -89.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MR9 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MR9 B 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2OO8 RELATED DB: PDB DBREF 2P4I A 808 1124 UNP Q02763 TIE2_HUMAN 808 1124 DBREF 2P4I B 808 1124 UNP Q02763 TIE2_HUMAN 808 1124 SEQRES 1 A 317 LYS ASN ASN PRO ASP PRO THR ILE TYR PRO VAL LEU ASP SEQRES 2 A 317 TRP ASN ASP ILE LYS PHE GLN ASP VAL ILE GLY GLU GLY SEQRES 3 A 317 ASN PHE GLY GLN VAL LEU LYS ALA ARG ILE LYS LYS ASP SEQRES 4 A 317 GLY LEU ARG MET ASP ALA ALA ILE LYS ARG MET LYS GLU SEQRES 5 A 317 TYR ALA SER LYS ASP ASP HIS ARG ASP PHE ALA GLY GLU SEQRES 6 A 317 LEU GLU VAL LEU CYS LYS LEU GLY HIS HIS PRO ASN ILE SEQRES 7 A 317 ILE ASN LEU LEU GLY ALA CYS GLU HIS ARG GLY TYR LEU SEQRES 8 A 317 TYR LEU ALA ILE GLU TYR ALA PRO HIS GLY ASN LEU LEU SEQRES 9 A 317 ASP PHE LEU ARG LYS SER ARG VAL LEU GLU THR ASP PRO SEQRES 10 A 317 ALA PHE ALA ILE ALA ASN SER THR ALA SER THR LEU SER SEQRES 11 A 317 SER GLN GLN LEU LEU HIS PHE ALA ALA ASP VAL ALA ARG SEQRES 12 A 317 GLY MET ASP TYR LEU SER GLN LYS GLN PHE ILE HIS ARG SEQRES 13 A 317 ASP LEU ALA ALA ARG ASN ILE LEU VAL GLY GLU ASN TYR SEQRES 14 A 317 VAL ALA LYS ILE ALA ASP PHE GLY LEU SER ARG GLY GLN SEQRES 15 A 317 GLU VAL TYR VAL LYS LYS THR MET GLY ARG LEU PRO VAL SEQRES 16 A 317 ARG TRP MET ALA ILE GLU SER LEU ASN TYR SER VAL TYR SEQRES 17 A 317 THR THR ASN SER ASP VAL TRP SER TYR GLY VAL LEU LEU SEQRES 18 A 317 TRP GLU ILE VAL SER LEU GLY GLY THR PRO TYR CYS GLY SEQRES 19 A 317 MET THR CYS ALA GLU LEU TYR GLU LYS LEU PRO GLN GLY SEQRES 20 A 317 TYR ARG LEU GLU LYS PRO LEU ASN CYS ASP ASP GLU VAL SEQRES 21 A 317 TYR ASP LEU MET ARG GLN CYS TRP ARG GLU LYS PRO TYR SEQRES 22 A 317 GLU ARG PRO SER PHE ALA GLN ILE LEU VAL SER LEU ASN SEQRES 23 A 317 ARG MET LEU GLU GLU ARG LYS THR TYR VAL ASN THR THR SEQRES 24 A 317 LEU TYR GLU LYS PHE THR TYR ALA GLY ILE ASP CYS SER SEQRES 25 A 317 ALA GLU GLU ALA ALA SEQRES 1 B 317 LYS ASN ASN PRO ASP PRO THR ILE TYR PRO VAL LEU ASP SEQRES 2 B 317 TRP ASN ASP ILE LYS PHE GLN ASP VAL ILE GLY GLU GLY SEQRES 3 B 317 ASN PHE GLY GLN VAL LEU LYS ALA ARG ILE LYS LYS ASP SEQRES 4 B 317 GLY LEU ARG MET ASP ALA ALA ILE LYS ARG MET LYS GLU SEQRES 5 B 317 TYR ALA SER LYS ASP ASP HIS ARG ASP PHE ALA GLY GLU SEQRES 6 B 317 LEU GLU VAL LEU CYS LYS LEU GLY HIS HIS PRO ASN ILE SEQRES 7 B 317 ILE ASN LEU LEU GLY ALA CYS GLU HIS ARG GLY TYR LEU SEQRES 8 B 317 TYR LEU ALA ILE GLU TYR ALA PRO HIS GLY ASN LEU LEU SEQRES 9 B 317 ASP PHE LEU ARG LYS SER ARG VAL LEU GLU THR ASP PRO SEQRES 10 B 317 ALA PHE ALA ILE ALA ASN SER THR ALA SER THR LEU SER SEQRES 11 B 317 SER GLN GLN LEU LEU HIS PHE ALA ALA ASP VAL ALA ARG SEQRES 12 B 317 GLY MET ASP TYR LEU SER GLN LYS GLN PHE ILE HIS ARG SEQRES 13 B 317 ASP LEU ALA ALA ARG ASN ILE LEU VAL GLY GLU ASN TYR SEQRES 14 B 317 VAL ALA LYS ILE ALA ASP PHE GLY LEU SER ARG GLY GLN SEQRES 15 B 317 GLU VAL TYR VAL LYS LYS THR MET GLY ARG LEU PRO VAL SEQRES 16 B 317 ARG TRP MET ALA ILE GLU SER LEU ASN TYR SER VAL TYR SEQRES 17 B 317 THR THR ASN SER ASP VAL TRP SER TYR GLY VAL LEU LEU SEQRES 18 B 317 TRP GLU ILE VAL SER LEU GLY GLY THR PRO TYR CYS GLY SEQRES 19 B 317 MET THR CYS ALA GLU LEU TYR GLU LYS LEU PRO GLN GLY SEQRES 20 B 317 TYR ARG LEU GLU LYS PRO LEU ASN CYS ASP ASP GLU VAL SEQRES 21 B 317 TYR ASP LEU MET ARG GLN CYS TRP ARG GLU LYS PRO TYR SEQRES 22 B 317 GLU ARG PRO SER PHE ALA GLN ILE LEU VAL SER LEU ASN SEQRES 23 B 317 ARG MET LEU GLU GLU ARG LYS THR TYR VAL ASN THR THR SEQRES 24 B 317 LEU TYR GLU LYS PHE THR TYR ALA GLY ILE ASP CYS SER SEQRES 25 B 317 ALA GLU GLU ALA ALA HET MR9 A 301 41 HET MR9 B 302 41 HETNAM MR9 4-METHYL-3-({3-[2-(METHYLAMINO)PYRIMIDIN-4-YL]PYRIDIN- HETNAM 2 MR9 2-YL}OXY)-N-[2-MORPHOLIN-4-YL-5-(TRIFLUOROMETHYL) HETNAM 3 MR9 PHENYL]BENZAMIDE FORMUL 3 MR9 2(C29 H27 F3 N6 O3) FORMUL 5 HOH *178(H2 O) HELIX 1 1 GLU A 872 LEU A 879 1 8 HELIX 2 2 ASN A 909 LYS A 916 1 8 HELIX 3 3 ARG A 918 ASP A 923 1 6 HELIX 4 4 ASP A 923 SER A 931 1 9 HELIX 5 5 SER A 937 LYS A 958 1 22 HELIX 6 6 ALA A 966 ARG A 968 5 3 HELIX 7 7 GLU A 974 TYR A 976 5 3 HELIX 8 8 PRO A 1001 MET A 1005 5 5 HELIX 9 9 ALA A 1006 ASN A 1011 1 6 HELIX 10 10 THR A 1016 SER A 1033 1 18 HELIX 11 11 THR A 1043 LEU A 1051 1 9 HELIX 12 12 ASP A 1064 CYS A 1074 1 11 HELIX 13 13 LYS A 1078 ARG A 1082 5 5 HELIX 14 14 SER A 1084 GLU A 1098 1 15 HELIX 15 15 LYS B 863 ARG B 867 5 5 HELIX 16 16 ASP B 868 LYS B 878 1 11 HELIX 17 17 ASN B 909 SER B 917 1 9 HELIX 18 18 ARG B 918 ASP B 923 1 6 HELIX 19 19 ASP B 923 ASN B 930 1 8 HELIX 20 20 SER B 937 LYS B 958 1 22 HELIX 21 21 ALA B 966 ARG B 968 5 3 HELIX 22 22 PRO B 1001 MET B 1005 5 5 HELIX 23 23 ALA B 1006 SER B 1013 1 8 HELIX 24 24 THR B 1016 SER B 1033 1 18 HELIX 25 25 THR B 1043 LEU B 1051 1 9 HELIX 26 26 PRO B 1052 GLY B 1054 5 3 HELIX 27 27 ASP B 1064 TRP B 1075 1 12 HELIX 28 28 LYS B 1078 ARG B 1082 5 5 HELIX 29 29 SER B 1084 GLU B 1098 1 15 SHEET 1 A 4 LEU A 839 ARG A 842 0 SHEET 2 A 4 ASP A 851 LYS A 855 -1 O ILE A 854 N LEU A 839 SHEET 3 A 4 LEU A 900 GLU A 903 -1 O ILE A 902 N ALA A 853 SHEET 4 A 4 LEU A 888 ALA A 891 -1 N GLY A 890 O ALA A 901 SHEET 1 B 2 ILE A 970 VAL A 972 0 SHEET 2 B 2 ALA A 978 ILE A 980 -1 O LYS A 979 N LEU A 971 SHEET 1 C 4 VAL B 838 ARG B 842 0 SHEET 2 C 4 ASP B 851 LYS B 855 -1 O ILE B 854 N LEU B 839 SHEET 3 C 4 LEU B 900 GLU B 903 -1 O ILE B 902 N ALA B 853 SHEET 4 C 4 LEU B 888 GLY B 890 -1 N GLY B 890 O ALA B 901 SHEET 1 D 2 ILE B 970 VAL B 972 0 SHEET 2 D 2 ALA B 978 ILE B 980 -1 O LYS B 979 N LEU B 971 SITE 1 AC1 16 VAL A 838 ALA A 853 GLU A 872 LEU A 879 SITE 2 AC1 16 ILE A 886 ILE A 902 GLU A 903 TYR A 904 SITE 3 AC1 16 ALA A 905 LEU A 955 HIS A 962 LEU A 971 SITE 4 AC1 16 ILE A 980 ALA A 981 ASP A 982 PHE A 983 SITE 1 AC2 16 ALA B 853 LYS B 855 GLU B 872 LEU B 876 SITE 2 AC2 16 ILE B 886 ILE B 902 GLU B 903 TYR B 904 SITE 3 AC2 16 ALA B 905 PHE B 960 HIS B 962 LEU B 971 SITE 4 AC2 16 ILE B 980 ALA B 981 ASP B 982 PHE B 983 CRYST1 64.262 63.189 175.571 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015561 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015826 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005696 0.00000